A drug control officer was arrested by the Directorate of Vigilance and AntiCorruption (DVAC) for demanding and accepting a bribe in Nagercoil.The accused, identified as Kathiravan (45) was caught ...

In a significant event showcasing India’s advancements in medical research and diagnostics, the Union Minister of State for Health and Family Welfare, Smt. Anupriya Patel inaugurated the National ...

A factory manufacturing Ayurvedic medicines illegally has been busted behind the Vishwambhari temple in Rabda, Valsad district of Gujarat. Food and Drug Administration (FDA) officials have raided the ...

Telangana Drug Control Administration (DCA) officials seized a stock of antibiotics and other medicines during a raid on the premises of a quack in Nizamabad district on September 10.The enforcement ...

The ICMR has licensed its multistage malaria vaccine AdFalciVax to five companies Indian Immunologicals Limited, Techinvention Lifecare Private Limited, Panacea Biotec Limited, Biological E Limited, ...

The Directorate General of Health Services has issued a directive asking physiotherapists not to use the ‘Dr.’ prefix, as they are not medical doctors.

The Delhi High Court on Tuesday directed the Central Drugs Standard Control Organisation (CDSCO) not to give effect to ...

Pelage Pharmaceuticals, a clinicalstage regenerative medicine company, today announced positive results from its Phase 2a clinical trial of PP405 — a topical therapy for androgenetic alopecia ...

New Delhi, 17 Sept 2024: The Central Drugs Standard Control Organization (CDSCO) has begun a 30-day consultation into proposed changes to the good clinical practice (GCP) guidelines in India. CDSCO ...

GENEVA, 24 JAN 2025: Nearly 10 million malaria vaccine doses were delivered to Africa during the first year of routine immunisation being rolled out across the continent, the Gavi vaccine alliance ...

New Delhi, 9 Dec 2022: CPI member P. Santhosh Kumar introduces his private member bill in the Rajya Sabha on December 9, 2022.

Maryland, 17 April 2024: The FDA slammed three Indian drugmakers with Form 483s following recent inspections that uncovered unsanitary conditions, broken equipment and poor recordkeeping.